Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

MLA

Jalkanen, Juho, et al. “Aberrant Circulating Levels of Purinergic Signaling Markers Are Associated with Several Key Aspects of Peripheral Atherosclerosis and Thrombosis.” Circulation Research, vol. 116, no. 7, Mar. 2015, pp. 1206–15. EBSCOhost, https://doi.org/10.1161/CIRCRESAHA.116.305715.

APA

Jalkanen, J., Yegutkin, G. G., Hollmén, M., Aalto, K., Kiviniemi, T., Salomaa, V., Jalkanen, S., & Hakovirta, H. (2015). Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. Circulation Research, 116(7), 1206–1215. https://doi.org/10.1161/CIRCRESAHA.116.305715

Chicago

Jalkanen, Juho, Gennady G Yegutkin, Maija Hollmén, Kristiina Aalto, Tuomas Kiviniemi, Veikko Salomaa, Sirpa Jalkanen, and Harri Hakovirta. 2015. “Aberrant Circulating Levels of Purinergic Signaling Markers Are Associated with Several Key Aspects of Peripheral Atherosclerosis and Thrombosis.” Circulation Research 116 (7): 1206–15. doi:10.1161/CIRCRESAHA.116.305715.